Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samuel Kyle
Observed names:
S. Kyle,
Sam Kyle,
Samuel D. Kyle
Institutions:
The University of Queensland,
Royal Brisbane and Women's Hospital
Observed institutions:
The University of Queensland,
Royal Brisbane and Women's Hospital,
Princess Alexandra Hospital,
Prince Charles Hospital,
University College London
ORCID:
0000-0001-5323-1855
Observed ORCID:
0000-0001-5323-1855
OpenAlex ID:
A5040694592
Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology
2018
·
Peter Donato
, Matthew J. Roberts
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
110
68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer
2020
·
Matthew J. Roberts
, Andrew Morton
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
104
68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
2020
·
Peter Donato
, Andrew Morton
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
101
The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma
2019
·
Sheliyan Raveenthiran
, Rachel Esler
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
79
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison
2021
·
Arsalan Tariq
, Michael Kwok
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
38
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)
2022
·
Arsalan Tariq
, Stephen McGeorge
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
18
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort
2024
·
Arsalan Tariq
, Adam Pearce
, et al.
·
European Urology Focus
·
10
PDF
Predicting tumour response
2013
·
Samuel D. Kyle
, W. Phillip Law
, et al.
·
Cancer Imaging
·
10
PDF
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
2023
·
Shivanshan Pathmanathan
, Arsalan Tariq
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
8
PDF
The role of dual tracer PSMA and FDG PET/CT in Renal Cell Carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison
2021
·
A. Tariq
, M. Kwok
, et al.
·
European Urology Open Science
·
3
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer
2020
·
Matthew J. Roberts
, Andrew Morton
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
3
PDF
Prostate‐specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesothelioma
2018
·
Siyaguna K. D. M. Ekanayake
, Ian A. Yang
, et al.
·
ANZ Journal of Surgery
·
3
Bilateral cryptorchidism mimicking external iliac lymphadenopathy in a patient with leg melanoma: role of FDG-PET and ultrasound in management
2014
·
Samuel Kyle
, W Phillip Law
·
Journal of Radiology Case Reports
·
1
PDF
Periosteal osteosarcoma
2011
·
Sam Kyle
, Yoshi Yu
, et al.
·
Radiopaedia.org
·
1
Protocol for PARA-PET: a trial of [ 18 F]fluorocholine PET/CT versus conventional imaging for primary hyperparathyroidism with randomised order of blinded imaging assessment
2026
·
Elizabeth Wootton
, Clement Wong
, et al.
·
BMJ Open
PDF
Radioactive Iodine Therapy Dosimetry for a Case of Functioning Follicular Thyroid Carcinoma Metastases
2026
·
Christopher James Kleimeyer
, Sarah Ong
, et al.
·
Research Square
PDF
Intrathyroid Parathyroid Adenoma Appearance on FCH PET / CT Imaging
2026
·
C. Kleimeyer
, S. Kyle
, et al.
·
ANZ Journal of Surgery
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC).
2022
·
Shivanshan Pathmanathan
, Arsalan Tariq
, et al.
·
Journal of Clinical Oncology
Metastatic renal cell carcinoma characterised by Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) / Computed Tomography (CT)
2021
·
A. Tariq
, A. Pearce
, et al.
·
European Urology Open Science
Characterisation of tumour thrombus in renal cell carcinoma with prostate specific membrane antigen positron emission tomography
2021
·
A. Tariq
, S.P. Mcgeorge
, et al.
·
European Urology Open Science
Prostate Specific Membrane Antigen (PSMA) PET/CT ligand uptake across histological sub-types of renal tumours
2021
·
A. Tariq
, A. Pearce
, et al.
·
European Urology
Prostate Specific Membrane Antigen (PSMA) PET/CT compared to standard of care imaging in the assessment of renal cancers: A multi-institutional series
2021
·
A. Tariq
, A. Pearce
, et al.
·
European Urology
CXCR4 positron emission tomography for the detection of bone disease in newly diagnosed myeloma
2019
·
Nicholas Weber
, Caitlin Thirunavukarasu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Mp74-18 Prostate Specific Membrane Antigen (psma) to Better Characterise Intraprostatic Tumour Burden: Review of an Academic, Tertiary Center Series
2019
·
Matthew Roberts*
, Peter Donato
, et al.
·
The Journal of Urology
PDF
Prostate-Specific Membrane Antigen Avidity on Positron Emission Tomography Scan in Malignant Pleural Mesothelioma
2019
·
Siyaguna Ekanayake
, Ian Yang
, et al.
·
Heart Lung and Circulation
Show more works
View as search
Works count:
29
Citation count:
489
H-index:
8
I10-index:
8
Year
Topic
Type